BILL ANALYSIS

HR8145

NEUTRAL

To amend the Distance Learning and Telemedicine Grants Program to expand eligibility for financial assistance to include the construction and enhancement of facilities and technological systems aimed at delivering telemedicine services, strengthening cybersecurity infrastructure, and supporting distance learning initiatives, including digital literacy, workforce development, and job training, in rural communities.

HR8145 (To amend the Distance Learning and Telemedicine Grants Program to expand eligibility for financial assistance to include the construction and enhancement of facilities and technological systems aimed at delivering telemedicine services, strengthening cybersecurity infrastructure, and supporting distance learning initiatives, including digital literacy, workforce development, and job training, in rural communities.) has been assessed with a neutral outlook for investors. The primary sectors impacted are Healthcare, Telecommunications and Technology. View the full bill text on Congress.gov.

neutral

Market Sentiment

Affected Stocks

Sectors Impacted

Key Takeaways for Investors

HR8145 is authorization-only with $0 in funding — it changes grant eligibility but provides no new money.

The bill is early-stage (introduced, referred to committee, 3 cosponsors) with a long and uncertain path to enactment.

Teladoc, Cisco, and rural telecom providers are structural beneficiaries only if the bill passes and receives appropriations, which is unlikely before late 2026 at the earliest.

How HR8145 Affects the Market

No near-term market implications. This is a procedural bill at the very beginning of the legislative process. Investors should not adjust positions based on HR8145. The telecom sector is currently in a broad 30-day selloff (VZ -4.94%, T -9.59%, TMUS -6.48%, CMCSA -6.06%) tied to earnings and interest rate concerns, not legislative catalysts. TDOC at $5.87 remains near its 52-week low and is driven by company-specific revenue challenges. CSCO at $90.31 is near its 52-week high on strong tech momentum but has no connection to this bill. Monitor if HR8145 is included as an amendment to the 2027 Farm Bill reauthorization — that would be the first material signal of legislative progress.

Bill Details

Metric	Value
Bill Number	HR8145
Market Sentiment	neutral
Event Date	March 27, 2026
Affected Sectors	Healthcare, Telecommunications, Technology
Affected Stocks	N/A
Source	View on Congress.gov →

Summary

HR8145 is an early-stage authorization-only bill that expands the USDA Distance Learning and Telemedicine Grants Program to include facility construction, cybersecurity, and workforce training. The bill authorizes $0 in funding, has only 3 cosponsors, and is referred to committee with no further action. There is zero near-term market impact. Teladoc, Cisco, and Comcast are structural beneficiaries if the bill ever passes and receives appropriations, but that outcome is uncertain and distant.

Full AI Market Analysis

HR8145, introduced March 27, 2026 by Rep. McClain Delaney (D-MD), amends the existing USDA Distance Learning and Telemedicine Grants Program (7 U.S.C. 950aaa-2) to expand eligible uses of grant funds. The bill broadens the program's scope from telemedicine and distance learning to include: (1) construction and enhancement of facilities and technological systems; (2) cybersecurity infrastructure; (3) digital literacy, workforce development, and job training — specifically including 'a workforce that supports the building of broadband in rural areas.' The bill is an authorization-only measure — it changes what the grant program CAN fund, but it does not appropriate any money. The existing program already has some annual appropriations (typically $40-60M via the Agriculture Appropriations bill), but HR8145 does not increase or guarantee any funding level. The bill has been referred to the House Committee on Agriculture and has accumulated only 3 cosponsors. No markup, no vote, no Senate companion bill exists. The legislative path forward requires passage through committee, floor votes in both chambers, and then a separate appropriations bill to provide actual dollars. Structural winners if funded include: Teladoc (TDOC) as the pure-play telemedicine platform that rural hospitals and clinics would purchase with grants; Cisco (CSCO) for its networking and cybersecurity hardware that rural facilities would need to build out telemedicine infrastructure; and rural broadband providers including Comcast (CMCSA), AT&T (T), Verizon (VZ), and T-Mobile (TMUS) who could use grants to offset rural deployment costs. However, the competitive impact is minimal — all companies would compete for a grant pool that doesn't yet exist with expanded eligibility that hasn't been authorized. Real market data shows no correlation with this bill. Over April 17-30, 2026, TDOC traded flat at ~$5.87 (+1.91% 7-day), CSCO rose to $90.31 (+1.46% 7-day, +16.39% 30-day) driven by broader tech momentum, and telecoms continued their 30-day declines (VZ -4.94%, T -9.59%, TMUS -6.48%, CMCSA -6.06%). These price movements reflect macro factors (interest rates, sector rotation, earnings), not legislative activity on an early-stage bill. Timeline: No further actions scheduled. The 119th Congress runs through January 2027. For this bill to have market impact, it must: (a) pass the House Agriculture Committee, (b) pass the full House, (c) pass the Senate (potentially as part of a Farm Bill reauthorization), (d) be signed into law, and then (e) receive appropriations in a subsequent spending bill. The earliest possible market impact would be late 2026 or 2027, and only if appropriations follow.